Replies to post #240466 on Biotech Values

[vinmantoo]

I will not be surprise seeing Molnupiravir approved by FDA regardless of its efficacy and AE. I hope PFE data are more solid

If the new analysis bears out the FDA will NOT approve Molnupiravir under EUA. They will have to generate more data.

So far, COVID vaccination did not stop the pandemics either.

PS
With such rapid COVID virus mutations, the present vaccine approach was a failure.

The opposite is true. Covid vaccinations have dramatically reduced Covid spread, serious illness, hospitalizations AND deaths in VACCINATED people. It is the large reservoir of UNVACCINATED people that is the problem. Anti-virals will certainly be needed to deal with unvaccinated people as well as to deal with new variants that might be able to make vaccines less effective.

[willyw]

With such rapid COVID virus mutations, the present vaccine approach was a failure.

Take a look at PFE (Pfizer) and MRNA (Moderna) charts today.

Pfizer has gone from roughly 40 to $50 dollars in about a month.
Moderna was up 27% earlier today.

It seems that a few people disagree with your thesis.